Solicitation of Nominations for Organizational Representatives to the Advisory Committee on Heritable Disorders in Newborns and Children, 65354-65356 [2018-27518]

Download as PDF 65354 Federal Register / Vol. 83, No. 244 / Thursday, December 20, 2018 / Notices Board of Governors of the Federal Reserve System, December 17, 2018. Yao-Chin Chao, Assistant Secretary of the Board. FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company [FR Doc. 2018–27575 Filed 12–19–18; 8:45 am] The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than January 7, 2019. A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. Edward J. Madden, Evanston, Illinois, individually and as trustee of the Edward J. Madden Declaration of Trust 3/6/2008; to join the Madden Family Group and to acquire voting shares of Schaumburg Bancshares, Inc., and thereby indirectly acquire shares of Heritage Bank of Schaumburg, both of Schaumburg, Illinois. BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; ACF’s Generic Clearance for Grant Reviewer Recruitment Forms (OMB #0970–0477) Office of Planning, Research, and Evaluation; Administration for Children and Families; HHS. ACTION: Request for public comment. AGENCY: The Administration for Children and Families (ACF), Office of Planning, Research, and Evaluation (OPRE) is proposing an extension of a currently approved generic clearance (OMB no. 0970–0477) for Grant Reviewer Recruitment (GRR) forms. The GRR forms will be used to select reviewers who will participate in the grant review process for the purpose of selecting successful applications. DATES: Comments due within 60 days of publication. In compliance with the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment SUMMARY: on the specific aspects of the information collection described above. ADDRESSES: Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Planning, Research, and Evaluation, 330 C Street SW, Washington, DC 20201, Attn: OPRE Reports Clearance Officer. Email address: OPREinfocollection@ acf.hhs.gov. All requests should be identified by the title of the information collection. SUPPLEMENTARY INFORMATION: Description: Under this generic approval, ACF conducts and proposes to continue to conduct more than one information collection that is very similar, voluntary, low-burden and uncontroversial. The purpose is to select qualified reviewers for the grant peer review process based on professional qualifications using data entered by candidates and the uploaded writing sample and/or curriculum vitae and/or resume. The grant review process is in accordance with the U.S. Department of Health and Human Services’ (DHHS) Grants Policy Directive (GPD) 2.04 ‘‘Awarding Grants’’, the DHHS Awarding Agency Grants Administration Manual (AAGAM), Chapter 2.04.104C ‘‘Objective Review of Grant Applications’’, and the Public Health Service (PHS) Act, Sections 799(f) and 806(e). Respondents: Individuals who may apply to review ACF grant applications. khammond on DSK30JT082PROD with NOTICES ANNUAL BURDEN ESTIMATES Instrument Total number of respondents Number of responses per respondent Average burden hours per response Annual burden hours Grant Reviewer Recruitment Form .................................................................. 3000 1 .5 1500 Estimated Total Annual Burden Hours: 1500. Comments: The Department specifically requests comments on (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information VerDate Sep<11>2014 17:21 Dec 19, 2018 Jkt 247001 technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Mary B. Jones, ACF/OPRE Certifying Officer. [FR Doc. 2018–27551 Filed 12–19–18; 8:45 am] BILLING CODE 4184–79–P PO 00000 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Solicitation of Nominations for Organizational Representatives to the Advisory Committee on Heritable Disorders in Newborns and Children Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Request for nominations. AGENCY: HRSA is seeking nominations from organizations to send a representative to be a liaison to the SUMMARY: Frm 00018 Fmt 4703 Sfmt 4703 E:\FR\FM\20DEN1.SGM 20DEN1 khammond on DSK30JT082PROD with NOTICES Federal Register / Vol. 83, No. 244 / Thursday, December 20, 2018 / Notices Advisory Committee on Heritable Disorders in Newborns and Children (Committee). Selections will be based on a review of the organization’s subject area of expertise, mission, relevancy, and benefit provided relative to the Committee’s purpose. The organizational representatives are nonvoting liaisons. The Committee provides advice, recommendations, and technical information about aspects of heritable disorders and newborn and childhood screening to the Secretary of HHS. HRSA is seeking nominations of qualified organizations to fill up to three positions. Authority: Section 1111 of the Public Health Service (PHS) Act, as amended by the Newborn Screening Saves Lives Reauthorization Act of 2014 (42 U.S.C. 300b–10). The Committee is governed by the Federal Advisory Committee Act (FACA), as amended (5 U.S.C. App.), and 41 CFR part 102–3, which set forth standards for the formation and use of advisory committees. DATES: Written nominations for organization representatives on the Committee must be received on or before January 17, 2019. ADDRESSES: Nomination packages must be submitted electronically as email attachments to Catharine Riley, Ph.D., MPH, Genetic Services Branch, Maternal and Child Health Bureau, HRSA, criley@hrsa.gov. FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO) Catharine Riley, Ph.D., MPH. Address: MCHB, HRSA 5600 Fishers Lane, Room 18–W–68, Rockville, MD 20857; phone number: 301–443–1291; email: criley@ hrsa.gov. A copy of the Committee Charter and list of the current membership can be obtained by accessing the Advisory Committee website at: www.hrsa.gov/advisorycommittees/heritable-disorders. SUPPLEMENTARY INFORMATION: The Committee is chartered under section 1111 of the PHS Act, as amended by the Newborn Screening Saves Lives Reauthorization Act of 2014 (42 U.S.C. 300b–10). The Committee was established in 2003 to advise the Secretary of HHS regarding newborn screening tests, technologies, policies, guidelines, and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders. In addition, the Committee provides advice and recommendations to the Secretary concerning the grants and projects authorized under section 1109 of the PHS Act and technical information to develop policies and priorities for grants, including those that will VerDate Sep<11>2014 17:21 Dec 19, 2018 Jkt 247001 enhance the ability of the state and local health agencies to provide for newborn and child screening, counseling and health care services for newborns, and children having or at risk for heritable disorders. The Committee also is governed by the provisions of FACA, as amended (5 U.S.C. App. 2), and 41 CFR part 102–3, which set forth standards for the formation and use of advisory committees. The Committee reviews and reports regularly on newborn and childhood screening practices for heritable disorders, recommends improvements in the national newborn and childhood heritable screening programs, and recommends conditions for inclusion in the Recommended Uniform Screening Panel (RUSP). The Committee’s recommendations regarding additional conditions/inherited disorders for screening that have been adopted by the Secretary of HHS are included in the RUSP and constitute part of the comprehensive guidelines supported by HRSA pursuant to section 2713 of the PHS Act, codified at 42 U.S.C. 300gg– 13. Under this provision, nongrandfathered health plans and group and individual health insurance issuers are required to cover screenings included in the HRSA-supported comprehensive guidelines without charging a co-payment, co-insurance, or deductible for plan years (i.e., in the individual market, policy years) beginning on or after the date that is 1 year from the Secretary’s adoption of the condition for screening. Nominations: The Committee may invite up to 15 organizations to designate individuals to serve as nonvoting liaisons. Organizations should demonstrate wide-ranging newborn screening and heritable disorders interests. In addition, the organization’s work should inform the activities of the Committee. Eligible organizations must represent national public health constituencies, medical professional societies, or organizations with large, broad constituencies and broad interest or involvement in newborn screening. Organizations which represent narrow interests (e.g., interest in a single disease or treatment) or smaller constituencies are not eligible. Organizational representatives attend Committee meetings to provide relevant expertise and perspectives to Committee members during their deliberations and discussions, but they do not vote and are not considered official members of the Committee. Applications must contain a cover letter and statement. The cover letter should include: Organization name and mission statement; contact information PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 65355 for the designated representative, including point of contact name, address, email, telephone number; and website of the organization. The statement should include: Perspective and expertise provided by the organization and its relevance to the Committee; a description of how the Committee’s work affects and impacts the organization and its constituency; a list of organizational projects, programs, and products that are of relevance to the Committee’s work; an affirmation of the organization’s commitment to identify a representative with expertise who can attend Committee meetings in person and provide input to the Committee, at the discretion of the Chairperson; an affirmation of the organization’s commitment to financially support (e.g., cover travel expenses) a representative to attend committee meetings held in Rockville, MD; an affirmation of the organization’s commitment to ensure active contribution to and dissemination of Committee activities and recommendations to its constituencies; affirmation the designated representative is able to serve as the liaison; and an affirmation that the organization has no conflict of interest that would preclude informing the Committee in a fair and balanced manner. If there are potential conflicts of interest, please detail the information concerning any possible conflicts of interest relative to both the organization and the proposed organizational representative (e.g., current or anticipated employment, consultancies, research grants, or contracts), as well as how the organization proposes to address the potential conflict. Organizations are eligible to send a representative as long as the organization’s subject area of expertise and mission is relevant to the Committee’s purpose, objective, scope of activities and duties, and as long as the organization actively participates on Committee activities. Every three years, the Chair and DFO will re-assess the organization’s mission, relevancy, and benefit as it relates to the Committee’s purpose, objective, scope of activities, and duties. Every three years current organizations will be asked to reaffirm their commitment to send an organizational representative. The selection of eligible organizations is based on a review of the organization’s subject area of expertise, mission, relevancy, and benefit as it relates to the Committee’s purpose. The Committee Charter, legislation, and list of current voting membership may be obtained by accessing the Committee website at http://www.hrsa.gov/ advisory-committees/heritable- E:\FR\FM\20DEN1.SGM 20DEN1 65356 Federal Register / Vol. 83, No. 244 / Thursday, December 20, 2018 / Notices disorders. Final selection of organizational representatives will be made by the Committee Chair and HRSA. Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–27518 Filed 12–19–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–7003–N–01] 60-Day Notice of Proposed Information Collection: Comment Request; Housing Discrimination Information Form; HUD–903.1, HUD–903.1A, HUD– 903.1B, HUD–903.1C, HUD–903.1F, HUD–903.1CAM, HUD–903.1KOR, HUD–903.1RUS, HUD–903–1_Somali Office of the Assistant Secretary for Fair Housing and Equal Opportunity, HUD. ACTION: Notice. AGENCY: The proposed reinstatement, without change, of a previously approved information collection for Housing Discrimination Information Form HUD–903.1, HUD–903.1A, HUD– 903.1B, HUD–903.1C, HUD–903.1F, HUD–903.1CAM, HUD–903.1KOR, HUD–903.1RUS, and HUD–903–1_ Somali will be submitted to the Office of Management and Budget (OMB) for review, in accordance with the Paperwork Reduction Act of 1995. HUD is soliciting comments from all interested parties on the proposed extension of this information collection. DATES: Comment Due Date: February 19, 2019. ADDRESSES: Interested persons are invited to submit comments regarding this proposed information collection. Comments should refer to the proposal by name and/or OMB Control Number, and should be sent to Inez C. Downs, Departmental Paperwork Reduction Act Officer, QMAC, U.S. Department of Housing and Urban Development, 451 7th Street SW, Room 4186, Washington, DC 20410–2000; telephone number (202) 402–8046 (this is not a toll-free number), or email at Inez.C.Downs@ hud.gov for a copy of the proposed forms or other available information; or to Colette Pollard, Departmental Paperwork Reduction Officer, QMAC, U.S. Department of Housing and Urban Development, 451 7th Street SW, Room 4186, Washington, DC 20410–2000; telephone number (202) 402–3400 (this is not a toll-free number), or email at khammond on DSK30JT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:21 Dec 19, 2018 Jkt 247001 Colette.Pollard@hud.gov for a copy of the proposed forms or other available information. Hearing or speech impaired individuals may access both numbers via TTY by calling the toll-free Federal Relay Service at: 1–(800) 877– 8339; FOR FURTHER INFORMATION CONTACT: Gordon F. Patterson, Department of Housing and Urban Development, 451 7th Street SW, Room 5214, Washington, DC 20410–2000; telephone number (202) 402–3264 (this is not a toll-free number). Hearing or speech impaired individuals may access this number via TTY by calling the toll-free Federal Relay Service at: 1–(800) 877–8339. SUPPLEMENTARY INFORMATION: HUD is submitting this proposed extension of a currently approved information collection to the OMB for review, as required by the Paperwork Reduction Act of 1995 [44 U.S.C. Chapter 35, as amended]. A. Overview of Information Collection This Notice is soliciting comments from members of the public and affected agencies concerning the proposed reinstatement, without change, of a previously approved collection of information regarding alleged discriminatory housing practices under the Fair Housing Act [42 U.S.C. 3601 et seq.]. The Fair Housing Act prohibits discrimination in the sale, rental, occupancy, advertising, and insuring of residential dwellings; and in residential real estate-related transactions; and in the provision of brokerage services, based on race, color, religion, sex, handicap [disability], familial status, or national origin. Any person who claims to have been injured by a discriminatory housing practice, or who believes that he or she will be injured by a discriminatory housing practice that is about to occur, may file a complaint with HUD not later than one year after the alleged discriminatory housing practice occurred or terminated. HUD has designed Housing Discrimination Information Form HUD–903.1 to promote consistency in the documents that, by statute, must be provided to persons against whom complaints are filed, and for the convenience of the general public. Section 103.25 of HUD’s Fair Housing Act regulation describes the information that must be included in each complaint filed with HUD. For purposes of meeting the Act’s one-year time limitation for filing complaints with HUD, complaints need not be initially submitted on the Form that HUD provides. Housing Discrimination Information Form HUD–903.1 (English PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 language), HUD–903.1A (Spanish language), HUD–903.1B (Chinese language), HUD–903.1C (Arabic language), HUD–903.1F (Vietnamese language), HUD–903.1CAM (Cambodian language), HUD–903.1KOR (Korean language), HUD–903.1RUS (Russian language), and HUD–903–1_(Somali language) may be submitted to HUD by mail, in person, by facsimile, by email, or via the internet to HUD’s Office of Fair Housing and Equal Opportunity (FHEO). FHEO staff uses the information provided on the Form to verify HUD’s authority to investigate the aggrieved person’s allegations under the Fair Housing Act. Title of Information Collection: Housing Discrimination Information Form. OMB Control Number: 2529–0011. Type of Request: Proposed reinstatement, without change, of a previously approved information collection. Form Number: HUD–903.1. Description of the need for the information and proposed use: HUD uses the Housing Discrimination Information Form HUD–903.1 (Form) to collect pertinent information from persons wishing to file housing discrimination complaints with HUD under the Fair Housing Act. The Fair Housing Act makes it unlawful to discriminate in the sale, rental, occupancy, advertising, or insuring of residential dwellings; or to discriminate in residential real estate-related transactions; or in the provision of brokerage services, based on race, color, religion, sex, handicap [disability], familial status, or national origin. Any person who claims to have been injured by a discriminatory housing practice, or any person who believes that he or she will be injured by a discriminatory housing practice that is about to occur, may file a complaint with HUD not later than one year after the alleged discriminatory housing practice occurs or terminates. The Form promotes consistency in the collection of information necessary to contact persons who file housing discrimination complaints with HUD. It also aids in the collection of information necessary for initial assessments of HUD’s authority to investigate alleged discriminatory housing practices under the Fair Housing Act. This information may subsequently be provided to persons against whom complaints are filed [‘‘respondents’’], as required under section 810(a)(1)(B)(ii) of the Fair Housing Act. Agency form numbers, if applicable: Form HUD–903.1 (English), Form HUD– 903.1A (Spanish), Form HUD–903.1B E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 83, Number 244 (Thursday, December 20, 2018)]
[Notices]
[Pages 65354-65356]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27518]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Solicitation of Nominations for Organizational Representatives to 
the Advisory Committee on Heritable Disorders in Newborns and Children

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Request for nominations.

-----------------------------------------------------------------------

SUMMARY: HRSA is seeking nominations from organizations to send a 
representative to be a liaison to the

[[Page 65355]]

Advisory Committee on Heritable Disorders in Newborns and Children 
(Committee). Selections will be based on a review of the organization's 
subject area of expertise, mission, relevancy, and benefit provided 
relative to the Committee's purpose. The organizational representatives 
are non-voting liaisons. The Committee provides advice, 
recommendations, and technical information about aspects of heritable 
disorders and newborn and childhood screening to the Secretary of HHS. 
HRSA is seeking nominations of qualified organizations to fill up to 
three positions.
    Authority: Section 1111 of the Public Health Service (PHS) Act, as 
amended by the Newborn Screening Saves Lives Reauthorization Act of 
2014 (42 U.S.C. 300b-10). The Committee is governed by the Federal 
Advisory Committee Act (FACA), as amended (5 U.S.C. App.), and 41 CFR 
part 102-3, which set forth standards for the formation and use of 
advisory committees.

DATES: Written nominations for organization representatives on the 
Committee must be received on or before January 17, 2019.

ADDRESSES: Nomination packages must be submitted electronically as 
email attachments to Catharine Riley, Ph.D., MPH, Genetic Services 
Branch, Maternal and Child Health Bureau, HRSA, criley@hrsa.gov.

FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO) 
Catharine Riley, Ph.D., MPH. Address: MCHB, HRSA 5600 Fishers Lane, 
Room 18-W-68, Rockville, MD 20857; phone number: 301-443-1291; email: 
criley@hrsa.gov. A copy of the Committee Charter and list of the 
current membership can be obtained by accessing the Advisory Committee 
website at: www.hrsa.gov/advisory-committees/heritable-disorders.

SUPPLEMENTARY INFORMATION: The Committee is chartered under section 
1111 of the PHS Act, as amended by the Newborn Screening Saves Lives 
Reauthorization Act of 2014 (42 U.S.C. 300b-10). The Committee was 
established in 2003 to advise the Secretary of HHS regarding newborn 
screening tests, technologies, policies, guidelines, and programs for 
effectively reducing morbidity and mortality in newborns and children 
having or at risk for heritable disorders. In addition, the Committee 
provides advice and recommendations to the Secretary concerning the 
grants and projects authorized under section 1109 of the PHS Act and 
technical information to develop policies and priorities for grants, 
including those that will enhance the ability of the state and local 
health agencies to provide for newborn and child screening, counseling 
and health care services for newborns, and children having or at risk 
for heritable disorders. The Committee also is governed by the 
provisions of FACA, as amended (5 U.S.C. App. 2), and 41 CFR part 102-
3, which set forth standards for the formation and use of advisory 
committees.
    The Committee reviews and reports regularly on newborn and 
childhood screening practices for heritable disorders, recommends 
improvements in the national newborn and childhood heritable screening 
programs, and recommends conditions for inclusion in the Recommended 
Uniform Screening Panel (RUSP). The Committee's recommendations 
regarding additional conditions/inherited disorders for screening that 
have been adopted by the Secretary of HHS are included in the RUSP and 
constitute part of the comprehensive guidelines supported by HRSA 
pursuant to section 2713 of the PHS Act, codified at 42 U.S.C. 300gg-
13. Under this provision, non-grandfathered health plans and group and 
individual health insurance issuers are required to cover screenings 
included in the HRSA-supported comprehensive guidelines without 
charging a co-payment, co-insurance, or deductible for plan years 
(i.e., in the individual market, policy years) beginning on or after 
the date that is 1 year from the Secretary's adoption of the condition 
for screening.
    Nominations: The Committee may invite up to 15 organizations to 
designate individuals to serve as non-voting liaisons. Organizations 
should demonstrate wide-ranging newborn screening and heritable 
disorders interests. In addition, the organization's work should inform 
the activities of the Committee. Eligible organizations must represent 
national public health constituencies, medical professional societies, 
or organizations with large, broad constituencies and broad interest or 
involvement in newborn screening. Organizations which represent narrow 
interests (e.g., interest in a single disease or treatment) or smaller 
constituencies are not eligible. Organizational representatives attend 
Committee meetings to provide relevant expertise and perspectives to 
Committee members during their deliberations and discussions, but they 
do not vote and are not considered official members of the Committee.
    Applications must contain a cover letter and statement. The cover 
letter should include: Organization name and mission statement; contact 
information for the designated representative, including point of 
contact name, address, email, telephone number; and website of the 
organization. The statement should include: Perspective and expertise 
provided by the organization and its relevance to the Committee; a 
description of how the Committee's work affects and impacts the 
organization and its constituency; a list of organizational projects, 
programs, and products that are of relevance to the Committee's work; 
an affirmation of the organization's commitment to identify a 
representative with expertise who can attend Committee meetings in 
person and provide input to the Committee, at the discretion of the 
Chairperson; an affirmation of the organization's commitment to 
financially support (e.g., cover travel expenses) a representative to 
attend committee meetings held in Rockville, MD; an affirmation of the 
organization's commitment to ensure active contribution to and 
dissemination of Committee activities and recommendations to its 
constituencies; affirmation the designated representative is able to 
serve as the liaison; and an affirmation that the organization has no 
conflict of interest that would preclude informing the Committee in a 
fair and balanced manner. If there are potential conflicts of interest, 
please detail the information concerning any possible conflicts of 
interest relative to both the organization and the proposed 
organizational representative (e.g., current or anticipated employment, 
consultancies, research grants, or contracts), as well as how the 
organization proposes to address the potential conflict.
    Organizations are eligible to send a representative as long as the 
organization's subject area of expertise and mission is relevant to the 
Committee's purpose, objective, scope of activities and duties, and as 
long as the organization actively participates on Committee activities. 
Every three years, the Chair and DFO will re-assess the organization's 
mission, relevancy, and benefit as it relates to the Committee's 
purpose, objective, scope of activities, and duties. Every three years 
current organizations will be asked to reaffirm their commitment to 
send an organizational representative.
    The selection of eligible organizations is based on a review of the 
organization's subject area of expertise, mission, relevancy, and 
benefit as it relates to the Committee's purpose. The Committee 
Charter, legislation, and list of current voting membership may be 
obtained by accessing the Committee website at http://www.hrsa.gov/
advisory-committees/heritable-

[[Page 65356]]

disorders. Final selection of organizational representatives will be 
made by the Committee Chair and HRSA.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-27518 Filed 12-19-18; 8:45 am]
 BILLING CODE 4165-15-P